Evidence map›Paper›PMID 37063826›Full record

ArticleFrontiers in immunology2023

Virulence capacity of different

Biao Chen, Guocheng Qian, Zhiya Yang, Ning Zhang, Yufeng Jiang, Dongmei Li, Renzhe Li, Dongmei Shi

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 6 citations in OpenAlex.

  1. Virulence ofVirulence · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Surveillance of Amphotericin B and Azole Resistance inJournal of fungi (Basel, Switzerland) · 2023
    Article
  8. Journal of fungi (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Biao ChenLaboratory of Medical Mycology, Jining No. 1 People's Hospital, Jining, Shandong, China.
Guocheng QianLaboratory of Medical Mycology, Jining No. 1 People's Hospital, Jining, Shandong, China.
Zhiya YangLaboratory of Medical Mycology, Jining No. 1 People's Hospital, Jining, Shandong, China.
Ning ZhangLaboratory of Medical Mycology, Jining No. 1 People's Hospital, Jining, Shandong, China.
Yufeng JiangLaboratory of Medical Mycology, Jining No. 1 People's Hospital, Jining, Shandong, China.
Dongmei LiGeorgetown University Medical Center, Department of Microbiology & Immunology, Washington, DC, United States.
Renzhe LiLaboratory of Medical Mycology, Jining No. 1 People's Hospital, Jining, Shandong, China.
Dongmei ShiLaboratory of Medical Mycology, Jining No. 1 People's Hospital, Jining, Shandong, China.
Jining First People's Hospital · CNGeorgetown University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The opportunistic filamentous fungus Methods: In the present study, host inflammation, antimicrobial susceptibilities and virulence were compared among clinical Results: A total of 46 strains were isolated from 45 patients with the invasive infection, of which 35 patients were diagnosed as IPA. Discussion:

Indexed as

Invasive Pulmonary AspergillosisAntifungal AgentsAspergillusAspergillus flavusHumansInflammationVirulenceAntifungal Agentsantifungal susceptibilityinflammationinvasive pulmonary aspergillosispolyphasic taxonomyvirulence

Identifiers

PMID37063826
PMCPMC10090689
OpenAlexW4361298153

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.